• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于临床病理的nomogram 模型的建立与验证:预测原发性肝癌经皮热消融术后种植转移风险。

Development and validation of a clinicopathological-based nomogram to predict seeding risk after percutaneous thermal ablation of primary liver carcinoma.

机构信息

Department of Minimal invasive intervention, Sun Yat-sen University Cancer Center, Guangzhou, China.

State Key Laboratory of Oncology in South China, Guangzhou, China.

出版信息

Cancer Med. 2020 Sep;9(18):6497-6506. doi: 10.1002/cam4.3250. Epub 2020 Jul 23.

DOI:10.1002/cam4.3250
PMID:32702175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7520297/
Abstract

OBJECTIVES

To develop a clinicopathological-based nomogram to improve the prediction of the seeding risk of after percutaneous thermal ablation (PTA) in primary liver carcinoma (PLC).

METHODS

A total of 2030 patients with PLC who underwent PTA were included between April 2009 and December 2018. The patients were grouped into a training dataset (n = 1024) and an external validation dataset (n = 1006). Baseline characteristics were collected to identify the risk factors of seeding after PTA. The multivariate Cox proportional hazards model based on the risk factors was used to develop the nomogram, which was used for assessment for its predictive accuracy using mainly the Harrell's C-index and receiver operating characteristic curve (AUC).

RESULTS

The median follow-up time was 30.3 months (range, 3.2-115.7 months). The seeding risk was 0.89% per tumor and 1.5% per patient in the training set. The nomogram was developed based on tumor size, subcapsular, α-fetoprotein (AFP), and international normalized ratio (INR). The 1-, 2-, and 3-year cumulative seeding rates were 0.1%, 0.7% and 1.2% in the low-risk group, and 1.7%, 6.3% and 6.3% in the high-risk group, respectively, showing significant statistical difference (P < .001). The nomogram had good calibration and discriminatory abilities in the training set, with C-indexes of 0.722 (95% confidence interval [CI]: 0.661, 0.883) and AUC of 0.850 (95% CI: 0.767, 0.934). External validation with 1000 bootstrapped sample sets showed a good C-index of 0.706 (95% CI: 0.546, 0.866) and AUC of 0.736 (95% CI: 0. 646, 0.827).

CONCLUSIONS

The clinicopathological-based nomogram could be used to quantify the probability of seeding risk after PTA in PLC.

摘要

目的

建立一种基于临床病理特征的列线图,以提高对原发性肝癌(PLC)经皮热消融(PTA)后种植风险的预测能力。

方法

本研究纳入了 2009 年 4 月至 2018 年 12 月期间接受 PTA 的 2030 例 PLC 患者。将患者分为训练数据集(n=1024)和外部验证数据集(n=1006)。收集基线特征,以确定 PTA 后种植的危险因素。基于危险因素的多变量 Cox 比例风险模型用于建立列线图,并主要使用 Harrell 的 C 指数和受试者工作特征曲线(AUC)评估其预测准确性。

结果

中位随访时间为 30.3 个月(范围:3.2-115.7 个月)。在训练集中,每个肿瘤的种植风险为 0.89%,每个患者的种植风险为 1.5%。该列线图是基于肿瘤大小、包膜下、甲胎蛋白(AFP)和国际标准化比值(INR)建立的。低危组的 1、2、3 年累积种植率分别为 0.1%、0.7%和 1.2%,高危组分别为 1.7%、6.3%和 6.3%,差异有统计学意义(P<0.001)。该列线图在训练集中具有良好的校准和区分能力,C 指数为 0.722(95%可信区间[CI]:0.661,0.883),AUC 为 0.850(95%CI:0.767,0.934)。对 1000 个 bootstrap 样本集进行外部验证显示,C 指数为 0.706(95%CI:0.546,0.866),AUC 为 0.736(95%CI:0.646,0.827),具有良好的效果。

结论

该基于临床病理特征的列线图可用于量化 PLC 患者 PTA 后种植风险的概率。

相似文献

1
Development and validation of a clinicopathological-based nomogram to predict seeding risk after percutaneous thermal ablation of primary liver carcinoma.基于临床病理的nomogram 模型的建立与验证:预测原发性肝癌经皮热消融术后种植转移风险。
Cancer Med. 2020 Sep;9(18):6497-6506. doi: 10.1002/cam4.3250. Epub 2020 Jul 23.
2
A novel nomogram to predict the local tumor progression after microwave ablation in patients with early-stage hepatocellular carcinoma: A tool in prediction of successful ablation.一种用于预测早期肝细胞癌患者微波消融后局部肿瘤进展的新诺莫图:一种预测消融成功的工具。
Cancer Med. 2020 Jan;9(1):104-115. doi: 10.1002/cam4.2606. Epub 2019 Nov 12.
3
Nomograms to predict survival outcomes after microwave ablation in elderly patients (>65 years old) with early-stage hepatocellular carcinoma.预测早期肝细胞癌老年患者(>65 岁)微波消融治疗后生存结局的列线图。
Int J Hyperthermia. 2020;37(1):808-818. doi: 10.1080/02656736.2020.1785556.
4
Sarcopenia predicts an adverse prognosis in patients with combined hepatocellular carcinoma and cholangiocarcinoma after surgery.肌肉减少症预示着接受手术治疗的肝细胞癌合并胆管细胞癌患者预后不良。
Cancer Med. 2022 Jan;11(2):317-331. doi: 10.1002/cam4.4448. Epub 2021 Dec 5.
5
Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.肝切除术后复发性肝细胞癌经皮热消融联合经动脉栓塞治疗的疗效及预测生存的预后列线图
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801362. doi: 10.1177/1533033818801362.
6
Nomograms to Predict the Disease-free Survival and Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.预测肝细胞癌射频消融术后无病生存期和总生存期的列线图
Intern Med. 2018 Feb 15;57(4):457-468. doi: 10.2169/internalmedicine.9064-17. Epub 2017 Nov 20.
7
Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.联合肝细胞癌(cHCC)患者肝切除术后总生存和无复发生存的综合列线图预测模型。
Aging (Albany NY). 2020 Aug 13;12(15):15334-15358. doi: 10.18632/aging.103577.
8
A Patient-Based Nomogram for Predicting Overall Survival after Radiofrequency Ablation for Hepatocellular Carcinoma.一种基于患者的列线图,用于预测肝细胞癌射频消融术后的总生存期。
J Vasc Interv Radiol. 2015 Dec;26(12):1787-94.e1. doi: 10.1016/j.jvir.2015.08.013. Epub 2015 Nov 2.
9
Prognostic Nomogram for Patients with Hepatocellular Carcinoma After Thermal Ablation.肝细胞癌热消融治疗后患者的预后列线图
Cardiovasc Intervent Radiol. 2020 Nov;43(11):1621-1630. doi: 10.1007/s00270-020-02617-z. Epub 2020 Aug 19.
10
Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.通过竞争风险列线图预测T1/2期肝细胞癌射频消融术后的癌症特异性死亡率:一项基于人群的分析。
Clin Res Hepatol Gastroenterol. 2024 Feb;48(2):102283. doi: 10.1016/j.clinre.2024.102283. Epub 2024 Jan 12.

引用本文的文献

1
A Nomogram Model to Predict Deep Vein Thrombosis Risk After Surgery in Patients with Hip Fractures.一种预测髋部骨折患者术后深静脉血栓形成风险的列线图模型。
Indian J Orthop. 2024 Jan 5;58(2):151-161. doi: 10.1007/s43465-023-01074-3. eCollection 2024 Feb.
2
Factors associated with increased risk of peritoneal seeding after radiofrequency ablation for hepatocellular carcinoma.射频消融治疗肝细胞癌后腹膜种植风险增加的相关因素。
Abdom Radiol (NY). 2023 Oct;48(10):3243-3252. doi: 10.1007/s00261-023-03987-x. Epub 2023 Jun 30.

本文引用的文献

1
Risk of needle tract seeding after coaxial ultrasound-guided percutaneous biopsy for primary and metastatic tumors of the liver: report of a single institution.同轴超声引导下经皮穿刺活检原发性和转移性肝脏肿瘤后针道种植的风险:单中心报告。
Abdom Radiol (NY). 2020 Oct;45(10):3301-3306. doi: 10.1007/s00261-019-02120-1.
2
Cancer treatment and survivorship statistics, 2019.2019 年癌症治疗与生存统计
CA Cancer J Clin. 2019 Sep;69(5):363-385. doi: 10.3322/caac.21565. Epub 2019 Jun 11.
3
Liver cancer incidence and mortality in China: Temporal trends and projections to 2030.
中国肝癌的发病率和死亡率:时间趋势及到2030年的预测
Chin J Cancer Res. 2018 Dec;30(6):571-579. doi: 10.21147/j.issn.1000-9604.2018.06.01.
4
Predictive value of the albumin-bilirubin grade on long-term outcomes of CT-guided percutaneous microwave ablation in intrahepatic cholangiocarcinoma.白蛋白-胆红素分级对 CT 引导下经皮微波消融治疗肝内胆管细胞癌长期疗效的预测价值。
Int J Hyperthermia. 2019;36(1):328-336. doi: 10.1080/02656736.2019.1567834. Epub 2019 Jan 28.
5
Cancer statistics, 2019.癌症统计数据,2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
6
Tumor Location Influences Oncologic Outcomes of Hepatocellular Carcinoma Patients Undergoing Radiofrequency Ablation.肿瘤位置对接受射频消融治疗的肝细胞癌患者肿瘤学结局的影响。
Cancers (Basel). 2018 Oct 10;10(10):378. doi: 10.3390/cancers10100378.
7
Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.肝切除术后复发性肝细胞癌经皮热消融联合经动脉栓塞治疗的疗效及预测生存的预后列线图
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818801362. doi: 10.1177/1533033818801362.
8
Ultrasound-guided percutaneous microwave ablation vs. surgical resection for thoracoabdominal wall implants from hepatocellular carcinoma: intermediate-term results.超声引导经皮微波消融与手术切除治疗肝癌累及胸腹壁种植灶的中期疗效比较。
Int J Hyperthermia. 2018 Nov;34(7):1067-1076. doi: 10.1080/02656736.2017.1402131. Epub 2017 Nov 21.
9
Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge.肝细胞癌射频消融术后针道种植:发生率、影响及管理挑战
J Hepatocell Carcinoma. 2017 Jan 20;4:23-27. doi: 10.2147/JHC.S106558. eCollection 2017.
10
Needle track seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma: 14-year experience at a single centre.肝细胞癌经皮射频消融术后针道种植:单中心14年经验
Int J Hyperthermia. 2017 Jun;33(4):454-458. doi: 10.1080/02656736.2017.1278630. Epub 2017 Jan 23.